Dawn has spent the past 19 years in the medical device industry working with venture capital backed start-ups and larger companies alike. She focuses her work on regulatory, strategy, and submissions, along with clinical study design and study execution, for products such as navigation devices for neurosurgical and cardiac indications, high intensity ultrasound for cardiac ablation, recombinant proteins for bone fusion, orthopedic trauma, vascular access, and imaging technologies.